Correction to “Effects of SGLT2 inhibitors on transplant survival and key clinical outcomes in heart transplant recipients with diabetes”

Documenti analoghi

• Effects of SGLT2 inhibitors on transplant survival and key clinical outcomes in heart transplant recipients with diabetes
  di: Fu‐Shun Yen, et al.
  Pubblicazione: (2025)
• Pyridoxine toxicity among lung transplant recipients
  di: Kavya Koshy, et al.
  Pubblicazione: (2026)
• COVID‐19 outcomes in haemopoietic stem cell transplant recipients in Western Australia: the value of vaccination and antiviral therapy
  di: Jacques A. J. Malherbe, et al.
  Pubblicazione: (2024)
• Feasibility and outcomes of kidney transplantation in patients with end‐stage kidney disease after haemopoietic stem cell transplantation
  di: Bioh Kim, et al.
  Pubblicazione: (2026)
• Prescription patterns of SGLT2 inhibitors in patients admitted to a tertiary health service with heart failure with reduced ejection fraction: an opportunity to improve
  di: Salim Memon, et al.
  Pubblicazione: (2026)